Madison, WINCT06159335Now EnrollingIRB Ready

Brain Metastasis Clinical Trial in Madison, WI

Access cutting-edge brain metastasis treatment through this phase 3 clinical trial at a research site in Madison. Study-provided care at no cost to qualified participants.

Sponsored by University of Wisconsin, Madison

Quick Self-Assessment

See if you qualify for this Madison location

Preparing your pre-screening questions…

Expert Care in Madison

Access brain metastasis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related brain metastasis treatment provided free

Apply for This Madison Location

Check if you qualify for this brain metastasis clinical trial in Madison, WI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Madison

    Convenient for WI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Madison site if eligible
  4. 4Begin participation

About This Brain Metastasis Study in Madison

The goal of this clinical trial is to use new imaging methods to help in finding out whether the imaging shows that there is a tumor in people with a brain metastasis. The main question it aims to answer is whether positron emission tomography (PET) and magnetic resonance imaging (MRI) find cancerous tissue better than other types of imagining. Participants will undergo a single PET/MRI scan, followed by a separate MRI scan with a tracer. Study participation will last about 3 hours.

Sponsor: University of Wisconsin, Madison

Who Can Participate

Inclusion Criteria

Age 18 years or older
Able and willing to provide informed consent
Has a brain metastasis diagnosis with at least one single visible contrast enhancing metastatic lesion on brain MRI
Received radiation therapy at some point in the last 2 years
Is currently being treated with or has been treated with any other concurrent systemic therapy (multi-modal therapy) in the past 6 months, which would include immunotherapy, targeted therapy, or systemic chemotherapy, immunotherapy, or chemotherapy following radiation therapy.
Patients are eligible for the study if their most recent standard-of-care MRI, used to assess disease location and extent, raises the question of tumor recurrence versus treatment-related changes. This concern can be noted by the radiologist or other members of the multidisciplinary care team, such as during a multidisciplinary conference. Additionally, if there are clinical concerns based on evolving exam findings or symptoms, and the treating physician suspects progression versus treatment-induced changes, the patient is also eligible for the study.
Be able to lie still for 30-60 minutes during the imaging procedure
Willing and able to undergo PET/MRI or PET/CT
Patients requiring intravenous (IV) conscious sedation for imaging are not eligible; patients requiring mild, oral anxiolytics for the clinical MRI will be allowed to participate as long as the following criteria are met:
The subject has their own prescription for the medication
The informed consent process is conducted prior to the self-administration of this medication
They come to the research visit with a driver

Exclusion Criteria

Subject unable or unwilling to provide informed consent
Subject is pregnant
Subject with contraindication(s) to or inability to undergo a PET/MR or PET/CT
Known allergy to 18F-Fluciclovine or any of its excipients

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Madison?

Yes, this clinical trial (NCT06159335) has an active research site in Madison, WI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Brain Metastasis Treatment Options in Madison, WI

If you're searching for brain metastasis treatment options in Madison, WI, this clinical trial (NCT06159335) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Madison research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced brain metastasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all brain metastasis clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Madison, WI

See all essential tremor clinical trials recruiting in Madison — not just this study.

Browse Essential Tremor Trials in Madison →

Browse More Trials by Condition

Essential Tremor TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Madison?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Madison, WI